20 December 2018 (Thursday) - Stem Cell Evidence Alert

I also received the “Stem Cell Evidence Alert” email today. This too was more of peripheral interest to me than of direct use, but I’m grateful for it anyway.

Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628)
von Bubnoff, N., Ihorst, G., et al.  BMC cancer 2018. Free Full Text

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia
Chhabra, S., Ahn, K. W., et all. Blood advances 2018. Free Full Text

Melphalan dose in myeloma patients >/=65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study
Ghilardi, G., Pabst, T., et al.  Bone marrow transplantation 2018

 Choosing a Reduced Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation, Fludarabine Busulfan versus Fludarabine Melphalan: A Systematic Review and Meta-analysis
Jain, T., Alahdab, F, et all. Biology of blood and marrow transplantation 2018

Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis
Montes de Jesus, F. M., Kwee, T. C., et al. Critical reviews in oncology/hematology 2018.

Impact of the Use and Type of Antibiotics on Acute Graft-versus-Host Disease
Nishi, K., Kanda, J., et all. Biology of blood and marrow transplantation 2018

Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis
Owattanapanich, W., Suphadirekkul, K., et al. BMC cancer 2018 Free Full Text

The Effect of Aging and Pre-Donation Comorbidities on the Related PBSC Donor Experience: A Report from the Related Donor Safety Study (RDSafe)
Pulsipher, M. A., Logan, B. R., et al. Biology of blood and marrow transplantation  2018

Effects of individualized nutrition after allogeneic hematopoietic stem cell transplantation following myeloablative conditioning; a randomized controlled trial
Skaarud, K. J., Hjermstad, M. J., et al. Clinical nutrition ESPEN ​2018

Droplet digital PCR for the simultaneous analysis of minimal residual disease and hematopoietic chimerism after allogeneic cell transplantation
Waterhouse, M., Pfeifer, D., et al. Clinical chemistry and laboratory medicine 2018